View Older Stories View More Recent Stories
-
Roth Capital Starts GSI Group (GSIG) at Buy
-
UPDATE: Coronado Biosciences (CNDO) Files 2M Common Stock Offering
-
Catalyst Pharma (CPRX) Closes 6M Offering at $0.80/Unit
-
Roth Capital Cuts Perfect World (PWRD) to Neutral Following Q1 Miss
-
Notable Analyst Rating Changes 05/29: (BTU) (TEX) (MT) Upgraded; (XOM) (STX) (GFA) Downgraded
-
Roth Capital Downgrades Ariba (ARBA) to Sell
-
Delcath Systems (DCTH) Announces Common, Warrants Offering
-
Notable Analyst Rating Changes 05/24: (PPG) (WPI) (DUK) Upgraded; (BHI) (HGSI) (COG) Downgraded
-
Roth Capital Starts Oxford Industries (OXM) at Buy
-
Roth Capital Starts Nektar Therapeutics (NKTR) at Buy
-
Roth Capital Starts Acadia Pharmaceuticals (ACAD) at Buy
-
Roth Capital Starts POZEN Inc. (POZN) at Buy
-
Roth Capital Starts Celsion Corp (CLSN) at Buy
-
Roth Capital Starts Celsion Corp (CLSN) at Buy
-
Roth Capital Upgrades Xueda Education (XUE) to Buy Following Q1 Results
-
Roth Capital Upgrades Uroplasty (UPI) to Buy
-
Roth Capital Upgrades Hollysys Automation Technologies (HOLI) to Buy
-
Roth Capital Upgrades China TransInfo Technology (CTFO) to Buy
-
Roth Capital Downgrades Sutor Technology Group (SUTR) to Neutral
-
Unusual 11 Mid-Day Movers 05/10: (ADY) (INSP) (RPRX) Higher; (SGI) (WFR) (ARX) Lower
-
Roth Capital Starts Energy Recovery (ERII) at Neutral
-
Notable Analyst Rating Changes 05/10: (TPX) (PRU) (KERX) Upgraded; (VRTX) (HGSI) (ORCL) Downgraded
-
Morning Movers 05/10: (ADY) (INSP) (KERX) (CYTX) Higher; (SGI) (CDTI) (ARX) (WFR) Lower
-
Roth Capital Downgrades Ariba (ARBA) to Neutral
-
Roth Capital Upgrades Keryx Biopharmaceuticals (KERX) to Buy
-
Roth Capital Upgrades U.S. Auto Parts Network (PRTS) to Buy
-
IMAX (IMAX) volatility low at 45
-
Roth Capital Starts iBio, Inc. (IBIO) at Buy
-
Roth Capital Downgrades PLX Technology (PLXT) to Neutral
-
Roth Capital Downgrades Changyou.com (CYOU) to Neutral
-
Roth Capital Downgrades Shuffle Master (SHFL) to Neutral
-
Roth Capital Upgrades Destination Maternity (DEST) to Buy
-
Roth Capital Starts LeapFrog (LF) at Buy, Sets $11 Target
-
Roth Capital Starts Spansion (CODE) at Buy
-
Notable Analyst Rating Changes 04/23: (JAKK) (RF) (LGF) Upgraded; (PGR) (FSLR) (LEN) Downgraded
-
Roth Capital Reinstates Coverage on CytRx Corp (CYTR) at Buy
-
Analysts Lift Targets on ICU Medical (ICUI) Following Q1 Earnings
-
Roth Capital Starts Patient Safety Technologies (PSTX) at Buy
-
Roth Capital Resumes Coverage on NovaBay Pharmaceuticals (NBY) at Buy
-
Roth Capital Starts Micron Technology (MU) at Buy
-
Roth Capital Starts Immunogen Inc. (IMGN) at Buy
-
Roth Capital Starts Questcor Pharmaceuticals (QCOR) at Buy
-
Roth Downgrade Weighs on Zhongpin (HOGS) Shares
-
Roth Capital Downgrades Zhongpin (HOGS) to Neutral
-
Roth Capital Starts Synergy Pharmaceuticals (SGYP) at Buy
-
Galena (GALE) Prices 8.5M Offering at $1.50/Share
-
After-Hours Movers 04/04: (APP) (BBBY) (BAS) Higher; (GALE) (RT) (CKEC) (HEAT) Lower
-
Galena Biopharma (GALE) Announces Common Offering
-
Roth Capital Downgrades Cavium Networks (CAVM) to Neutral
-
Roth Capital Downgrades Keryx Biopharmaceuticals (KERX) to Neutral

